ASSOCIATIE DERMATOLOGIE Suys Erwin en Bonny Michiel FV
- Address
- lock Available on a paid plan
Dermatology Clinical Research at ASSOCIATIE DERMATOLOGIE Suys Erwin en Bonny Michiel FV
This site in Kortrijk, Belgium is focused on Skin and Connective Tissue Diseases, with clinical trials centered on atopic dermatitis and moderate-to-severe psoriasis. The research is aimed at improving day-to-day disease control and evaluating new treatment approaches for people living with chronic inflammatory skin conditions.
- Studies in psoriasis are examining whether proactive treatment monitoring can help maintain better long-term control with biologic therapies.
- Research in atopic dermatitis is assessing the effectiveness of ruxolitinib cream for adults who need alternative options after standard topical treatments.
- The overall focus is on testing therapies that may improve symptom relief, disease stability, and treatment options in common chronic dermatologic disorders.
With a small but specialized portfolio of clinical trials, the site contributes to practical research on treatment effectiveness and better management strategies in dermatology.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Universitair Ziekenhuis Gent1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Amgen Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in ASSOCIATIE DERMATOLOGIE Suys Erwin en Bonny Michiel FV
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND) | Amgen Inc. | Phase III | Not Recruiting | Oct 2023 | Jun 2026 |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rocatinlimab | 2 | Unknown | 2023-05-11 | 2023-10-20 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.